Tobacco stocks crushed as FDA targets nicotine
- Author: Santos West Aug 07, 2017,
Aug 07, 2017, 0:49
FDA commissioner Scott Gottlieb said in a speech that "we need to envision a world where cigarettes lose their addictive potential through nicotine levels". FDA has been largely trying to shift smokers from cigarettes to e-cigarettes and vaporizers as they have little or no amount of nicotine in them. Mr. Donny, the director of Pitt's Center for the Evaluation of Nicotine in Cigarettes, argued that most of the harm linked with smoking isn't caused by nicotine.
"The proprietary tobacco used in MAGIC cigarettes is grown on independently-owned farms in the United States and results in an extraordinary cigarette with all of the taste of a conventional cigarette, but MAGIC yields only 0.04 mg of nicotine per cigarette - 95% less nicotine than conventional cigarettes". Under expected revised timelines, applications for newly-regulated combustible products, such as cigars, pipe tobacco and hookah tobacco, would be submitted by August 8, 2021, and applications for non-combustible products such as ENDS or e-cigarettes would be submitted by August 8, 2022.
'It doesn't read like the industry is destined to go up in smoke, ' he said.
If successful, the effort would be the first time the government has tried to get the Americans to quit cigarettes beyond the warning labels or additional taxes to aiming at the actual addictive substance inside. The FDA wants smokers to switch to smokeless tobacco and e-cigarettes, as well, the Wall Street Journal reports.
According to Commissioner Gottlieb, the approach to nicotine must be accompanied by a strict base of rules and standards for newly-regulated products which should be done in concert and not in isolation, if it is to be successful. There is no evidence that switching to lower tar cigarettes becomes less dependent or helps the smoker stop smoking.
Additionally, the FDA expects that manufacturers would continue to market products while the agency reviews product applications.
The FDA's announcement sets in motion a lengthy rule-making process that will involve public comment and input from multiple stakeholders before any measures take effect.